Clinical Trial Update: Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing recombinant follicle-stimulating hormone with highly purified urinary FSH in women with Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• highly purified urinary follicle-stimulating hormone (follicle-stimulating hormone)
• recombinant follicle-stimulating hormone (recombinant follicle-stimulating hormone)

Snippet

Sponsor: Genesis Center for Fertility & Human Pre-Implantation Genetics | Conditions: Polycystic Ovary Syndrome | Phase 2 | Status: UNKNOWN